Jamf Holding Corp. (JAMF)
NASDAQ: JAMF · Real-Time Price · USD
7.40
-0.54 (-6.80%)
At close: Aug 1, 2025, 4:00 PM
7.54
+0.14 (1.89%)
After-hours: Aug 1, 2025, 5:24 PM EDT
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $16.9, which forecasts a 128.38% increase in the stock price over the next year. The lowest target is $10 and the highest is $27.
Price Target: $16.90 (+128.38%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $15 → $10 | Hold | Maintains | $15 → $10 | +35.14% | Jul 21, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +62.16% | Jul 17, 2025 |
| Needham | Needham | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +170.27% | Jul 17, 2025 |
| Mizuho | Mizuho | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | +75.68% | Jul 16, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $15 → $12 | Hold | Maintains | $15 → $12 | +62.16% | Jul 16, 2025 |
Financial Forecast
Revenue This Year
706.79M
from 627.40M
Increased by 12.65%
Revenue Next Year
770.57M
from 706.79M
Increased by 9.02%
EPS This Year
0.84
from -0.53
EPS Next Year
0.99
from 0.84
Increased by 17.42%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 729.5M | 806.9M | 886.4M |
| Avg | 706.8M | 770.6M | 837.5M |
| Low | 677.2M | 721.3M | 773.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 16.3% | 14.2% | 15.0% |
| Avg | 12.7% | 9.0% | 8.7% |
| Low | 7.9% | 2.1% | 0.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.01 | 1.21 | 1.14 |
| Avg | 0.84 | 0.99 | 1.01 |
| Low | 0.77 | 0.78 | 0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 43.2% | 15.6% |
| Avg | - | 17.4% | 1.6% |
| Low | - | -7.0% | -18.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.